HCAT vs PGNY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

HCAT

47.9
AI Score
VS
PGNY Wins

PGNY

50.9
AI Score

Investment Advisor Scores

HCAT

48score
Recommendation
HOLD

PGNY

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HCAT PGNY Winner
Revenue 70.76M 328.50M PGNY
Net Income -111.03M 24.23M PGNY
Net Margin -156.9% 7.4% PGNY
Operating Income -106.48M 35.38M PGNY
ROE -80.4% 5.5% PGNY
ROA -26.9% 3.5% PGNY
Total Assets 412.20M 698.34M PGNY
Cash 59.86M 131.61M PGNY
Current Ratio 1.69 2.13 PGNY
Free Cash Flow 18.17M 39.60M PGNY

Relative Price Performance (Last 90 Days)

HCAT 1M: +1.0% · 3M: +67.2% PGNY 1M: +5.7% · 3M: +67.5%

Current Technical Phase

HCAT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (20.8% over 20 days), RSI 52

RSI (14): 52.1 · Price: $2.09

PGNY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (18.1% over 20 days), RSI 57

RSI (14): 57.3 · Price: $31.13

Fundamentals Snapshot

Metric HCAT PGNY
Market Cap
Forward P/E 22.6 13.9
Trailing P/E 40.9
Revenue (TTM)
Revenue Growth -0.1% 0.0%
Gross Margin 0.5% 0.2%
Operating Margin -0.1% 0.1%
EPS -3.57 0.77
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PGNY is currently the stronger investment candidate, winning 10 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.